Skip to main content
Fig. 5 | Health Economics Review

Fig. 5

From: Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting

Fig. 5

Cost-effectiveness acceptability curves (CEAC) for all strategies based on highest net monetary benefits at each willingness-to-pay (WTP) threshold. CEACs appearing to the left of or in between the vertical lines representing the WTP-threshold range of €25 000–€50 000 per quality-adjusted life year (QALY) are considered cost-effective with a probability corresponding to the relevant WTP-threshold

Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us